Learn more about uBriGene's CAR-T CDMO manufacturing for high-quality therapies.
Download Brochure
Learn how uBriGene can be your bridge from ATMPs concept to commercialization.
Explore uBriGene’s robust GMP plasmid manufacturing process and testing capabilities.
Power of IVT-produced highly stable mRNA + microflu-idics LNP encapsulation
uBriGene's LVV manufacturing platform accelerates time to clinic with ready-to-use cell lines and LVV helper plasmids for high-quality, large-scale vector production.
uBriGene's iPSC CDMO platforms deliver GMP-compliant cell therapy development with advanced production, strict quality testing, and full IND support.
uBriGene provides comprehensive CRO services for CGT, including tech transfer, process development, and scale-up, helping clients reduce timelines and costs.
Learn more about uBriGene's CAR-T CDMO manufacturing for high-quality therapies.
uBriGene's AAV manufacturing platform speeds time to clinic with off-the-shelf cell lines and AAV helper plasmids, enabling high-quality vector production up to 2000L scale.
